Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.

Issue 15, 2020
Previous Article Next Article

Mechanism of action of the curcumin cis-diammineplatinum(ii) complex as a photocytotoxic agent

Author affiliations


In the search for new and more active anticancer drugs, light-activated compounds are emerging as effective drugs to be used in photodynamic therapy (PDT) and photoactivated chemotherapy (PACT). These clinical treatments are able to overcome severe side effects caused by the conventional Pt(II) complexes in chemotherapy, since the cytotoxic species are released directly into the target regions, reducing toxicity in healthy tissues. The curcumin cis-diammineplatinum(II) complex has been proposed for PACT as it allows the controlled release of aquated diammine–platinum(II) species as a DNA cross-linking agent and curcumin as a potential photosensitizer, thus working as a dual action anticancer agent. The curcumin ligand dissociation upon irradiation with visible light was examined by means of DFT and TD-DFT calculations. The outcomes clearly unraveled the metal-centered triplet states 3MC as active species involved in the photocleavage of curcumin that lead to the formation of aquated platinum species and ruled out the potential activity of such a complex in the dark.

Graphical abstract: Mechanism of action of the curcumin cis-diammineplatinum(ii) complex as a photocytotoxic agent

Back to tab navigation

Supplementary files

Article information

07 May 2020
09 Jun 2020
First published
10 Jun 2020

Inorg. Chem. Front., 2020,7, 2759-2769
Article type
Research Article

Mechanism of action of the curcumin cis-diammineplatinum(II) complex as a photocytotoxic agent

E. Dabbish, G. Mazzone, N. Russo and E. Sicilia, Inorg. Chem. Front., 2020, 7, 2759
DOI: 10.1039/D0QI00503G

Social activity

Search articles by author